Tower Research Capital LLC TRC Acquires New Shares in Innovator IBD 50 ETF (NYSEARCA:FFTY)

Tower Research Capital LLC TRC Acquires New Shares in Innovator IBD 50 ETF (NYSEARCA:FFTY)


Tower Research Capital LLC TRC acquired a new stake in shares of the Innovator IBD 50 ETF (NYSEARCA:FFTY – Free Report) during the third quarter, the company said in its most recent Form 13F filing with the Securities and Exchange Commission. The company acquired 16,399 shares of the company’s stock, valued at approximately $367,000. Tower Research Capital LLC TRC owns approximately 0.37% of the Innovator IBD 50 ETF according to its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Money Concepts Capital Corp lifted its holdings in Innovator IBD 50 ETF by 511.8% during the 4th quarter. Money Concepts Capital Corp now owns 2,068 shares of the company’s stock worth $45,000 after purchasing an additional 1,730 shares during the period. National Bank of Canada FI raised its holdings in the Innovator IBD 50 ETF by 1,366.7% during the third quarter. Canadian National Bank FI now owns 2,200 shares of the company’s stock worth $49,000 after purchasing an additional 2,050 shares during the period. Coastal Investment Advisors Inc. Acquired a new position in the Innovator IBD 50 ETF during the second quarter valued at approximately $62,000. JPMorgan Chase & Co. raised its holdings in the Innovator IBD 50 ETF by 610.5% during the second quarter. JPMorgan Chase & Co. owns 4,000 shares of the company’s stock are now worth $102,000 after purchasing an additional 3,437 shares during the period. Finally, Bank of America Corp DE lifted its holdings in the Innovator IBD 50 ETF by 47.7% during the first quarter. Bank of America Corp DE now owns 4,982 shares of the company’s stock worth $118,000 after purchasing an additional 1,608 shares during the period.

Innovator IBD 50 ETF traded down 0.6%

FFTY shares opened at $27.23 on Monday. The company has a market capitalization of $119.81 million, a P/E ratio of 16.51 and a beta of 1.14. The Innovator IBD 50 ETF has a 12-month low of $20.55 and a 12-month high of $28.26. The stock’s 50 day moving average price is $25.71 and its two-hundred day moving average price is $23.88.

Innovator IBD 50 ETF Profile

(Free report)
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund based on the IBD 50 Index. The fund tracks an index of 50 U.S.-listed stocks with strong growth characteristics. Collectibles are selected based on fundamental and technical classifications. FFTY was launched on April 9, 2015 and is managed by Innovator.

Recommended stories

Want to know what other hedge funds are holding FFTY? Visit HoldingsChannel.com for the latest 13F filings and insider trades for the Innovator IBD 50 ETF (NYSEARCA:FFTY – Free Report).

Institutional Ownership by Quarter for Innovator IBD 50 ETF (NYSEARCA:FFTY)



Get news and reviews for the Innovator IBD 50 ETF daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for the Innovator IBD 50 ETF and related companies with MarketBeat.com’s free daily email newsletter.

    (tags for translation) Innovator IBD 50 ETF 

You may also like...

Leave a Reply